Anaesthesia for patients with idiopathic environmental intolerance and chronic fatigue syndrome

British Journal of Anaesthesia

Volumn 101, Issue 4, 2008, Pages 486-491

  Fisher, M McD ^a   Rose, M ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Allergy; Anaesthesia, adverse effects; Chronic fatigue syndrome; Idiopathic environmental intolerance; Multiple chemical sensitivities

Indexed keywords

ANESTHETIC AGENT; ATRACURIUM; BUPIVACAINE; FENTANYL; GLYCOPYRRONIUM BROMIDE; INHALATION ANESTHETIC AGENT; ISOFLURANE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MORPHINE; NITROUS OXIDE; PROPOFOL; THIOPENTAL; VASOCONSTRICTOR AGENT;

ALLERGY; AMNESIA; ANAPHYLAXIS; ANESTHESIA; ANESTHESIST; ARTERIAL PRESSURE; ARTICLE; BRONCHOSPASM; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HALLUCINATION; HEMIPLEGIA; HUMAN; IDIOPATHIC ENVIRONMENTAL INTOLERANCE; INTERNET; MALE; MEDICAL LITERATURE; MULTIPLE CHEMICAL SENSITIVITY; NARCOLEPSY; PATIENT REFERRAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SCIENTIFIC LITERATURE; SEIZURE; SIDE EFFECT; SWELLING; SYNCOPE; UNSPECIFIED SIDE EFFECT; URTICARIA;

ANESTHESIA; DRUG HYPERSENSITIVITY; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; MALE; MULTIPLE CHEMICAL SENSITIVITY; POSTOPERATIVE COMPLICATIONS; SKIN TESTS;

EID: 51849150019     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen242     Document Type: Article

References (46)

1. American Academy of Allergy, Asthma and Immunology. Position Statement. Available from http://www.aaaai.org/media/resources/ academy_statements/position_statementsps35.asp
2. Kipen HM, Fiedler N. Environmental factors in medically unexplained symptoms and related syndromes: the evidence and the challenge. Environ Health Perspect 2002; 110: 597-9
3. Engel CC, Adkins JA, Cowan DN. Caring for medically unexplained physical symptoms after toxic environmental exposures: effects of contested causation. Environ Health Perspect 2002; 110: 641-7
4. Das-Munshi J, Rubin G J, Wessely S. Multiple chemical sensitivities: a systematic review of provocation studies. J Allergy Clin Immunol 2006; 118: 1257-64
5. Dumit J. Illnesses you have to fight to get: facts as forces in uncertain, emergent illnesses. Soc Sci Med 2006; 62: 577-90
6. Kreutzer R, Neutra RR, Lausuay N. Prevalence of people reporting sensitivities to chemicals in a population based survey. Am J Epidemiol 1999; 150: 1-12
7. Feidler N, Kippen HM, DeLuca J, Kelly-McNeil KBA, Natelson B. A controlled comparison of multiple chemical sensitivities and chronic fatigue syndrome. Psychosom Med 1996; 58: 38-49
8. Buchwald D, Umali P, Umali J, Kith P, Pearlman T, Komaroff AL. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system. Ann Intern Med 1995; 123: 81-8
9. Scottish Short Life Working Party. Chronic fatigue syndrome/myalgic encephalomyelitis. Outline for Development of Services for CFS/ME in Scotland, December 2002
10. Fisher M. Intradermal testing after anaphylactoid reactions to anaesthetic drugs: practical aspects of performance and interpretation. Anaesth Intensive Care 1984; 12: 115-20
11. Fisher M, Bowey CJ. Alleged allergy to local anaesthetics. Anaesth Intensive Care 1997; 25: 611-4
12. Ziem G, McTamney J. Profile of patients with chemical injury and sensitivity. Environ Health Perspect 1997; 105: 417-36
13. Niedoszytko M, Chelminska M, Buss T, Roik E, Jassem E. Drug intolerance in patients with idiopathic environmental intolerance syndrome. Int J Clin Pract 2006; 60: 1327-9
14. Hattori J, Fujimura N, Kanaya N, Okazaki K, Namiki A. Bronchospasm induced by propofol in a patient with sick house syndrome. Anesth Analg 2003; 96: 163-4
15. Meenaksi Kumar V. Anaesthetic management of two patients with myalgic encephalomyelitis. Indian J Anaesth 2003; 47: 57-9
16. Cooper CH. Multiple chemical sensitivity in the clinical setting: although the cause and diagnosis of this condition remain controversial, the patients concerns should be heeded. Am J Nurs 2007; 107: 40-7
17. Crean EA. CFIDS and anaesthesia: what are the risks? Available from http://www.cfids.org./archives/2000/2000-1-article03.asp
18. McIntyre A. Anesthesia and CFIDS. Available from http://www.cfids.org/ archives/2001/2001-4-onetoone.asp
19. Beck S. Tips for anesthetics and hospitalization for patients with multiple chemical sensitivities. Available from http://www.immuneweb.org/ articles/anaesthetics.html
20. Kaplan M. Surgery, anesthesia and CFS/MCS. Available from http://www.anapsid.org/cnd/drugs/anesthesia.htm
21. Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. J Am Med Assoc 1995; 274: 961-7
22. Streeten DH, Thomas D, Bell DS. The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci 2000; 320: 1-8
23. Streeten DH. Role of impaired lower-limb venous innervation in the pathogenesis of chronic fatigue syndrome. Am J Med Sci 2001; 321: 163-7
24. Karas B, Grubb BP, Boehm J, Kip K. The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents. Pacing Clin Electrophysiol 2000; 23: 344-51
25. Jones JF, Nicholson A, Nisenbaum R, et al. Orthostatic instability in a population-based study of chronic fatigue syndrome. Am J Med 2005; 118: 1415
26. Cowie DA, Shoemaker JK, Gelb AW. Orthostatic hypotension occurs frequently in the first hour after anesthesia. Anesth Analg 2004; 98: 40-45b
27. Garland EM, Robertson D. Chiari I malformation as a cause of orthostatic intolerance symptoms: a media myth? Am J Med 2001; 111: 546-52
28. 2 consumption and physical activity in patients with chronic fatigue. Am J Physiol Heart Circ Physiol 2002; 282: H66-71
29. Yoshiuchi K, Farkas J, Natelson BH. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin Physiol Funct Imaging 2006; 26: 83-6
30. Tanaka H, Matsushima R, Tamai H, Kajimoto Y. Impaired postural cerebral hemodynamics in young patients with chronic fatigue with and without orthostatic intolerance. J Pediatr 2002; 140: 412-7
31. Fischler B, D'Haenen H, Cluydts R, et al. Comparison of 99m Tc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: an exploratory study of clinical correlates of regional cerebral blood flow. Neuropsychobiology 1996; 34: 175-83
32. Razumovsky AY, DeBusk K, Calkins H, et al. Cerebral and systemic hemodynamics changes during upright tilt in chronic fatigue syndrome. J Neuroimaging 2003; 13: 57-67
33. Cox IM, Campbell MJ, Dowson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet 1991; 337: 757-60
34. Moorkens G, Manuel y Keenoy B, Vertommen J, Meludu S, Noe M, De Leeuw I. Magnesium deficit in a sample of the Belgian population presenting with chronic fatigue. Magnes Res 1997; 10: 329-37
35. Hinds G, Bell NP, McMaster D, McCluskey DR. Normal red cell magnesium concentrations and magnesium loading tests in patients with chronic fatigue syndrome. Ann Clin Biochem 1994; 31: 459-61
36. Lloyd AR, Wakefield D, Boughton CR, Dwyer JM. Immunological abnormalities in the chronic fatigue syndrome. Med J Aust 1989; 151: 122-4
37. Straus SE, Dale JK, Wright R, Metcalfe DD. Allergy and the chronic fatigue syndrome. J Allergy Clin Immunol 1988; 81: 791-5
38. Steinberg P, McNutt BE, Marshall PA, et al. Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome. J Allergy Clin Immunol 1996; 97: 119-26
39. Ferré Ybarz L, Cardona Dahl V, Cadahía García A, et al. Prevalence of atopy in chronic fatigue syndrome. Allergol Immunopathol (Madr) 2005; 33: 42-7
40. Brunet JL, Fatoohi F, Liaudet AP, Cozon GJ. Role of pathological delayed-type hypersensitivity in chronic fatigue syndrome: importance of the evaluation of lymphocyte activation by flow cytometry and the measurement of urinary neopterin. Allerg Immunol 2002; 34: 38-44
41. Kowal K, Schacterele RS, Schur PH, Komaroff AL, DuBuske LM. Prevalence of allergen-specific IgE among patients with chronic fatigue syndrome. Allergy Asthma Proc 2002; 23: 35-9
42. Repka-Ramirez MS, Naranch K, Park YJ, Velarde A, Clauw D, Baraniuk JN. IgE levels are the same in chronic fatigue syndrome (CFS) and control subjects when stratified by allergy skin test results and rhinitis types. Ann Allergy Asthma Immunol 2001; 87: 218-21
43. Winkler AS, Blair D, Marsden JT, Peters TJ, Wessely S, Cleare AJ. Autonomic function and serum erythropoietin levels in chronic fatigue syndrome. J Psychosom Res 2004; 56: 179-83
44. Natelson BH, Haghighi MH, Ponzio NM. Evidence for the presence of immune dysfunction in chronic fatigue syndrome. Clin Diagn Lab Immunol 2002; 9: 747-52
45. Jones JF, Maloney EM, Boneva RS, Jones AB, Reeves WC. Complementary and alternative medical therapy utilization by people with chronic fatiguing illnesses in the United States. BMC Altern Med 2007; 7: 12
46. Centers for Disease Control. Chronic Fatigue Syndrome. Available from http://www.cdc.gov/cfs/cfsbasicfacts.htm